- Which you don't agree with until YOUR kid comes down with e-coli, since you guys are against inspection (regulation). ?
Abolish the FDA!!
The FDA has failed
This attempt by the government to insure consumers against the risk of using drugs and medical devices has flopped on numerous occasions. First of all, FDA regulations have often prevented U.S. consumers from gaining access to new life-saving drugs. Examples of this include major delays in the marketing of drugs used to treat cancer, blood pressure, heart attacks, cholesterol, and strokes and delays in marketing such high-tech items as cardiac pacemakers and in the use of such techniques as balloon angioplasty for blocked coronary arteries. For many years, the FDA would not allow the makers of aspirin to claim on their product labels that aspirins thinned blood and could thus save one from dying if taken during a heart attack. The costs of FDA regulation of these markets has likely run into the billions, possibly hundreds of billions, of dollars and is composed of higher drug prices, fewer drugs, and more and lengthier illnesses and earlier deaths.
In a call to the Bush Administration to merely reform the FDA, Henry I. Miller, a fellow at the Hoover Institution and the Competitive Enterprise Institute and a former FDA official, presented a devastating critique of the FDAs regulatory process and procedures.
In his early 2001 editorial commentary, Dr. Miller stated that the total time it takes to develop a new drug had doubled since the 1960's. And the costs to a manufacturer of bringing a single new drug to market had risen to over $400 million, the highest cost in the world. He further contended: "Costs are spiraling out of control because the FDA meddles endlessly in clinical trials and keeps raising the bar for approval." Furthermore, he cited statistics that showed the average number of clinical trials per average drug increased from 30 in the early 1980's to 68 during the 199495 period while the average number of patients in clinical trials for each drug more than tripled! As expected, the average time required for clinical trials for a new drug rose from 85 months in the first half of the 1990's to 92 months in the last half of the 1990's."
.